Compositional Analysis and Metabolism of Human Milk Oligosaccharides in Infants.
@article{Kunz2017CompositionalAA,
title={Compositional Analysis and Metabolism of Human Milk Oligosaccharides in Infants.},
author={Clemens Kunz and Silvia Rudloff},
journal={Nestle Nutrition Institute workshop series},
year={2017},
volume={88},
pages={
137-147
}
}It is a great success that biotechnological means are available today to produce amounts of single human milk oligosaccharides (HMOs) in a purity which allows performing metabolic and functional studies even in humans. As recent data indicate that there is a link between the Lewis blood group and the secretor status of an individual and certain inflammatory diseases, this review will also focus on the metabolic fate of secretor- and Lewis blood group-specific components. We conclude that there…
10 Citations
Human Milk Oligosaccharides: A Comprehensive Review towards Metabolomics
- BiologyChildren
- 2021
A review of the application of metabolomics to investigate the HMOs, by using Pubmed, Researchgate and Scopus as source databases, finds that in the future, this could be possible by using a dipstick and adding the eventual missing oligosaccharide to the breast milk or formula in order to give the best and the most personalized nutritional regimen for each newborn.
Maternal and Infant Factors Associated with Human Milk Oligosaccharides Concentrations According to Secretor and Lewis Phenotypes
- BiologyNutrients
- 2019
Unprecedented data on HMOs concentrations from breastfeeding Brazilian women and novel associations of maternal allergic disease and infant’s sex with H MOs concentrations are presented.
Does the contribution of human milk oligosaccharides to the beneficial effects of breast milk allow us to hope for an improvement in infant formulas?
- MedicineCritical reviews in food science and nutrition
- 2020
Better understanding of the role of HMOs leading to the development of inexpensive methods for large-scale HMO production is needed, and randomized controlled trials are restricted to structurally simple compounds such as 2’ fucosyllactose and lacto-N-neotetraose.
Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
- MedicineNutrients
- 2018
The limited clinical data suggest that the addition of HMOs to infant formula seems to be safe and well tolerated, inducing a normal growth and suggesting a trend towards health benefits.
In silico analysis of the human milk oligosaccharide glycome reveals key enzymes of their biosynthesis
- Biology
- 2022
This work adapted a model of mucin-type GalNAc-linked glycosylation enzymes to act on free lactose, identifying a subset of 11 enzyme activities that can account for 206 of 226 distinct HMOs isolated from human milk, and constructed a biosynthetic reaction network that identifies 5 new core HMO structures.
Prebiotics: Mechanisms and Preventive Effects in Allergy
- BiologyNutrients
- 2019
Both the mechanisms and the therapeutic evidence from preclinical and clinical studies exploring the role of prebiotics in allergy prevention are described.
Activation of the G-protein coupled receptor GPR35 by human milk oligosaccharides through different pathways
- BiologyScientific reports
- 2020
A remarkable cooperation between nutrition and microbiota towards activation of a host receptor highlighting the close interplay between environment and host-microbe interactions is demonstrated.
The clinical impact of maternal weight on offspring health: lights and shadows in breast milk metabolome
- MedicineExpert review of proteomics
- 2021
The potential effects of metabolites found altered in breast milk of overweight/obese mothers are investigated, through an extensive review of metabolomics studies, and the potential short- and long-term clinical effects in the offspring are investigated.
References
SHOWING 1-10 OF 56 REFERENCES
Milk oligosaccharides and metabolism in infants.
- BiologyAdvances in nutrition
- 2012
In this review, the current knowledge about the metabolic aspects of HMO in infants is summarized starting with the first studies by Lundblad and co-workers in the early 1980s and closes with a perspective on some important questions regarding metabolic and functional aspects ofHMO.
13C-labeled oligosaccharides in breastfed infants' urine: individual-, structure- and time-dependent differences in the excretion.
- BiologyGlycobiology
- 2014
The data suggest that neutral HMOs might be processed and/or utilized differentially after or upon absorption from the gut, as deduced from their structure-dependent variation in the extent of tracer enrichment and in the retention times in infant's organism.
Metabolic fate of neutral human milk oligosaccharides in exclusively breast-fed infants.
- MedicineMolecular nutrition & food research
- 2015
This study reveals new insights into the metabolism of neutral HMO in exclusively breast-fed infants and provides further indications for multiple factors influencing HMO metabolism and functions that should be considered in future in vivo investigations.
A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants
- MedicineAnalytical and Bioanalytical Chemistry
- 2013
A method employing nanoflow liquid chromatography time-of-flight mass spectrometry (MS) is presented to simultaneously identify and quantify HMOs in the feces and urine of infants to provide diagnostic and therapeutic opportunities.
Urinary excretion of in vivo 13C-labelled milk oligosaccharides in breastfed infants
- MedicineBritish Journal of Nutrition
- 2011
Investigation of metabolic aspects in infants after endogenous 13C-labelling of HMO confirmed the excretion of a variety of neutral and acidic HMO without metabolic modification of their structures.
Influence of Gestational Age, Secretor, and Lewis Blood Group Status on the Oligosaccharide Content of Human Milk
- MedicineJournal of pediatric gastroenterology and nutrition
- 2017
Investigating whether differences exist between term and preterm milk, milk from mothers with secretor or nonsecretor status, and a Lewis blood group (a+b−), (a−b+), or ( a−b−) pattern found marked differences in total and single HMOs in milk depending onLewis blood group and secretor status.
Neutral oligosaccharides in feces of breastfed and formula-fed infants at different ages.
- MedicineGlycobiology
- 2016
Alternative explanations are suggested for the described association of oligosaccharide excretion with age and feeding type in infants below 7 months of age.
Historical aspects of human milk oligosaccharides.
- MedicineAdvances in nutrition
- 2012
This review focuses on important observations regarding infant health around 1900 when breastfeeding was not considered a matter of importance. The discovery of lactobacilli and bifidobacteria and…
Human milk oligosaccharides: every baby needs a sugar mama.
- BiologyGlycobiology
- 2012
An accumulating body of evidence suggests that HMOs are antiadhesive antimicrobials that serve as soluble decoy receptors, prevent pathogen attachment to infant mucosal surfaces and lower the risk for viral, bacterial and protozoan parasite infections.

